Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer
NCT03444844
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer Recurrent
Prostate Cancer
Interventions
DRUG:
Ga-68 P16-093 PET/CT scan
Sponsor
Five Eleven Pharma, Inc.
Collaborators
[object Object]